Get the latest Science News and Discoveries
New screening tool could improve the survival rate of patients with hepatocellular carcinoma from 20% to 90% - EurekAlert
Early diagnosis of hepatocellular carcinoma (HCC)—one of the most fatal malignancies—is crucial to improve patient survival. In a breakthrough study investigators report on the development of a serum fusion-gene machine-learning model. This important screening tool may increase the five-year survival rate of patients with HCC from 20% to 90% because of its improved accuracy in early diagnosis of HCC and monitoring the impact of treatment. The study appears in The American Journal of Pathology, published by Elsevier.
None
Or read this on Eureka Alert